Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
about
Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β.Protective Effect of the Total Flavonoids from Rosa laevigata Michx Fruit on Renal Ischemia-Reperfusion Injury through Suppression of Oxidative Stress and Inflammation.Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling.Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.Drugs and Targets in Fibrosis.Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice.Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo.Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway.Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.Tanshinol ameliorates CCl4-induced liver fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κB/IκBα signaling pathway.Fibroblast growth factor receptor 1 antagonism attenuates lipopolysaccharide-induced activation of hepatic stellate cells via suppressing inflammation
P2860
Q33591426-AA1F283C-3EAD-486C-9A18-4E53806E64E9Q37702357-66642EC4-FDB1-4D82-911E-AE86C51B85DDQ38644414-A1140B5E-C801-4CE4-8BBF-B2B1C1E1717DQ38756031-C2140400-1A09-486B-A784-3F2B6E4BDE2FQ38972122-A029D4CD-368E-4357-8922-489DBC2AE551Q39169974-3949E233-126D-495C-B1A1-E24C2C258A45Q47119118-A3D97031-D3F4-4CF6-9AC0-2AC21EA4C27AQ47135902-41447032-957C-4587-83A3-4F1D1505D22AQ47222057-9E4A2355-0D51-4439-AD54-903A99F71BA3Q51186424-B9A68D70-FE3E-4CBA-969D-1404295C594AQ52663010-A04168E2-6452-4170-9801-63585DC13409Q55264899-84F9E1D2-CD4A-475A-A0D1-4C54E190FE68Q58796655-F1AAA921-9B51-4D11-8C9A-25A7E14AA716
P2860
Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Dioscin alleviates BDL- and DM ...... nhibition of p38 MAPK pathway.
@en
type
label
Dioscin alleviates BDL- and DM ...... nhibition of p38 MAPK pathway.
@en
prefLabel
Dioscin alleviates BDL- and DM ...... nhibition of p38 MAPK pathway.
@en
P2093
P1476
Dioscin alleviates BDL- and DM ...... nhibition of p38 MAPK pathway.
@en
P2093
Jinyong Peng
Lianhong Yin
Xufeng Tao
P356
10.1016/J.TAAP.2015.12.024
P577
2015-12-30T00:00:00Z